Cargando…
Evaluation of confirmatory data following the Article 12 MRL review for fludioxonil
The applicant Syngenta submitted a request to the competent national authority in France to evaluate the confirmatory data that were identified in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. The applicant provided residue...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009037/ https://www.ncbi.nlm.nih.gov/pubmed/32626430 http://dx.doi.org/10.2903/j.efsa.2019.5812 |
_version_ | 1783495576601493504 |
---|---|
author | Anastassiadou, Maria Brancato, Alba Carrasco Cabrera, Luis Ferreira, Lucien Greco, Luna Jarrah, Samira Kazocina, Aija Leuschner, Renata Magrans, Jose Oriol Miron, Ileana Nave, Stefanie Pedersen, Ragnor Reich, Hermine Rojas, Alejandro Sacchi, Angela Santos, Miguel Stanek, Alois Theobald, Anne Vagenende, Benedicte Verani, Alessia |
author_facet | Anastassiadou, Maria Brancato, Alba Carrasco Cabrera, Luis Ferreira, Lucien Greco, Luna Jarrah, Samira Kazocina, Aija Leuschner, Renata Magrans, Jose Oriol Miron, Ileana Nave, Stefanie Pedersen, Ragnor Reich, Hermine Rojas, Alejandro Sacchi, Angela Santos, Miguel Stanek, Alois Theobald, Anne Vagenende, Benedicte Verani, Alessia |
collection | PubMed |
description | The applicant Syngenta submitted a request to the competent national authority in France to evaluate the confirmatory data that were identified in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. The applicant provided residue trials on strawberries representative for an adjusted Good Agricultural Practice (GAP) and a new feeding study in ruminants. The data gaps identified in the MRL review were considered satisfactorily addressed, except for the southern adjusted GAP on strawberries. The new residue data confirm the existing tentative MRL for strawberries; EFSA proposed – based on the new feeding study in ruminants – amendments of the existing MRLs for certain animal products for further risk management consideration. EFSA updated the most recent consumer risk assessment for fludioxonil and concluded that the long‐term dietary intake is unlikely to present a risk to consumer health. |
format | Online Article Text |
id | pubmed-7009037 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70090372020-07-02 Evaluation of confirmatory data following the Article 12 MRL review for fludioxonil Anastassiadou, Maria Brancato, Alba Carrasco Cabrera, Luis Ferreira, Lucien Greco, Luna Jarrah, Samira Kazocina, Aija Leuschner, Renata Magrans, Jose Oriol Miron, Ileana Nave, Stefanie Pedersen, Ragnor Reich, Hermine Rojas, Alejandro Sacchi, Angela Santos, Miguel Stanek, Alois Theobald, Anne Vagenende, Benedicte Verani, Alessia EFSA J Reasoned Opinion The applicant Syngenta submitted a request to the competent national authority in France to evaluate the confirmatory data that were identified in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. The applicant provided residue trials on strawberries representative for an adjusted Good Agricultural Practice (GAP) and a new feeding study in ruminants. The data gaps identified in the MRL review were considered satisfactorily addressed, except for the southern adjusted GAP on strawberries. The new residue data confirm the existing tentative MRL for strawberries; EFSA proposed – based on the new feeding study in ruminants – amendments of the existing MRLs for certain animal products for further risk management consideration. EFSA updated the most recent consumer risk assessment for fludioxonil and concluded that the long‐term dietary intake is unlikely to present a risk to consumer health. John Wiley and Sons Inc. 2019-09-17 /pmc/articles/PMC7009037/ /pubmed/32626430 http://dx.doi.org/10.2903/j.efsa.2019.5812 Text en © 2019 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made. |
spellingShingle | Reasoned Opinion Anastassiadou, Maria Brancato, Alba Carrasco Cabrera, Luis Ferreira, Lucien Greco, Luna Jarrah, Samira Kazocina, Aija Leuschner, Renata Magrans, Jose Oriol Miron, Ileana Nave, Stefanie Pedersen, Ragnor Reich, Hermine Rojas, Alejandro Sacchi, Angela Santos, Miguel Stanek, Alois Theobald, Anne Vagenende, Benedicte Verani, Alessia Evaluation of confirmatory data following the Article 12 MRL review for fludioxonil |
title | Evaluation of confirmatory data following the Article 12 MRL review for fludioxonil |
title_full | Evaluation of confirmatory data following the Article 12 MRL review for fludioxonil |
title_fullStr | Evaluation of confirmatory data following the Article 12 MRL review for fludioxonil |
title_full_unstemmed | Evaluation of confirmatory data following the Article 12 MRL review for fludioxonil |
title_short | Evaluation of confirmatory data following the Article 12 MRL review for fludioxonil |
title_sort | evaluation of confirmatory data following the article 12 mrl review for fludioxonil |
topic | Reasoned Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009037/ https://www.ncbi.nlm.nih.gov/pubmed/32626430 http://dx.doi.org/10.2903/j.efsa.2019.5812 |
work_keys_str_mv | AT evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT anastassiadoumaria evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT brancatoalba evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT carrascocabreraluis evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT ferreiralucien evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT grecoluna evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT jarrahsamira evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT kazocinaaija evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT leuschnerrenata evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT magransjoseoriol evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT mironileana evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT navestefanie evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT pedersenragnor evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT reichhermine evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT rojasalejandro evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT sacchiangela evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT santosmiguel evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT stanekalois evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT theobaldanne evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT vagenendebenedicte evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil AT veranialessia evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil |